🇺🇸 FDA
Pipeline program

Dextrose / glucose 5% solution in water, Setrusumab

UX143-CL301

Phase 3 small_molecule active

Quick answer

Dextrose / glucose 5% solution in water, Setrusumab for Osteogenesis imperfecta (OI) is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharma Mar S.A.
Indication
Osteogenesis imperfecta (OI)
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials